Increasing evidence suggested that alterations of phosphatidylinositol-3-kinases (PI3K)/Akt/mTOR pathway were identified and involved in the pathogenesis of lung cancer for therapeutic strategy [26]. Here, AKT1 is linked to lung carcinoma.